Literature DB >> 24769898

TACC3 deregulates the DNA damage response and confers sensitivity to radiation and PARP inhibition.

G-H Ha1, J-L Kim1, A Petersson1, S Oh2, M F Denning3, T Patel4, E-K Breuer1.   

Abstract

Deregulation of the transforming acidic coiled-coil protein 3 (TACC3), an important factor in the centrosome-microtubule system, has been linked to a variety of human cancer types. We have recently reported on the oncogenic potential of TACC3; however, the molecular mechanisms by which TACC3 mediates oncogenic function remain to be elucidated. In this study, we show that high levels of TACC3 lead to the accumulation of DNA double-strand breaks (DSBs) and disrupt the normal cellular response to DNA damage, at least in part, by negatively regulating the expression of ataxia telangiectasia mutated (ATM) and the subsequent DNA damage response (DDR) signaling cascade. Cells expressing high levels of TACC3 display defective checkpoints and DSB-mediated homologous recombination (HR) and non-homologous end joining (NHEJ) repair systems, leading to genomic instability. Importantly, high levels of TACC3 confer cellular sensitization to radiation and poly(ADP-ribose) polymerase (PARP) inhibition. Overall, our findings provide critical information regarding the mechanisms by which TACC3 contributes to genomic instability, potentially leading to cancer development, and suggest a novel prognostic, diagnostic and therapeutic strategy for the treatment of cancer types expressing high levels of TACC3.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24769898     DOI: 10.1038/onc.2014.105

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.

Authors:  Kotaro Matsuda; Hiroaki Miyoshi; Koji Hiraoka; Tetsuya Hamada; Kazutaka Nakashima; Naoto Shiba; Koichi Ohshima
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

2.  Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.

Authors:  Ji Hae Nahm; Haeryoung Kim; Hyejung Lee; Jai Young Cho; Young Rok Choi; Yoo-Seok Yoon; Ho-Seong Han; Young Nyun Park
Journal:  Tumour Biol       Date:  2015-07-29

Review 3.  Ectopic Expression of Testis Germ Cell Proteins in Cancer and Its Potential Role in Genomic Instability.

Authors:  Aaraby Yoheswaran Nielsen; Morten Frier Gjerstorff
Journal:  Int J Mol Sci       Date:  2016-06-06       Impact factor: 5.923

Review 4.  The Ran Pathway in Drosophila melanogaster Mitosis.

Authors:  Jack W C Chen; Amy R Barker; James G Wakefield
Journal:  Front Cell Dev Biol       Date:  2015-11-26

5.  TACC3 in personalized medicine.

Authors:  Stephen Murata; Loredana Campo; Eun-Kyoung Breuer
Journal:  Oncoscience       Date:  2015-08-31

Review 6.  Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine.

Authors:  Stephen Murata; Catherine Zhang; Nathan Finch; Kevin Zhang; Loredana Campo; Eun-Kyoung Breuer
Journal:  Biomed Res Int       Date:  2016-08-24       Impact factor: 3.411

7.  TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Authors:  Rainer Fagerholm; Sofia Khan; Marjanka K Schmidt; Montserrat García-Closas; Päivi Heikkilä; Jani Saarela; Jonathan Beesley; Maral Jamshidi; Kristiina Aittomäki; Jianjun Liu; H Raza Ali; Irene L Andrulis; Matthias W Beckmann; Sabine Behrens; Fiona M Blows; Hermann Brenner; Jenny Chang-Claude; Fergus J Couch; Kamila Czene; Peter A Fasching; Jonine Figueroa; Giuseppe Floris; Gord Glendon; Qi Guo; Per Hall; Emily Hallberg; Ute Hamann; Bernd Holleczek; Maartje J Hooning; John L Hopper; Agnes Jager; Maria Kabisch; Renske Keeman; Veli-Matti Kosma; Diether Lambrechts; Annika Lindblom; Arto Mannermaa; Sara Margolin; Elena Provenzano; Mitul Shah; Melissa C Southey; Joe Dennis; Michael Lush; Kyriaki Michailidou; Qin Wang; Manjeet K Bolla; Alison M Dunning; Douglas F Easton; Paul D P Pharoah; Georgia Chenevix-Trench; Carl Blomqvist; Heli Nevanlinna
Journal:  Oncotarget       Date:  2017-03-14

8.  Inhibiting of TACC3 Promotes Cell Proliferation, Cell Invasion and the EMT Pathway in Breast Cancer.

Authors:  Qin Huo; Siqi Chen; Zhenwei Li; Juan Wang; Jiaying Li; Ni Xie
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

9.  High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.

Authors:  Zhi-Liang Huang; Zhi-Rui Lin; Yi-Ren Xiao; Xun Cao; Lin-Chun Zhu; Mu-Sheng Zeng; Qian Zhong; Zhe-Sheng Wen
Journal:  Oncotarget       Date:  2015-03-30

10.  Systematic Identification of Oncogenic EGFR Interaction Partners.

Authors:  Julia Petschnigg; Max Kotlyar; Louise Blair; Igor Jurisica; Igor Stagljar; Robin Ketteler
Journal:  J Mol Biol       Date:  2016-12-09       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.